NamitaSoodMD

Pulmonology • Sacramento, CA

Critical Care Medicine, Interstitial Lung Diseases, Pulmonary Vascular Medicine

Professor, Internal Medicine

Join to view full profile

Dr. Sood is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Sood's full profile

Already have an account?

Office
2825 J St Ste 400
Sacramento, CA 95816
Phone+1 916-734-5360

Fax+1 916-734-5582

Summary

Dr. Namita Sood is a pulmonologist in Sacramento,CA. She received her medical degree from University of Tripoli School of Medicine and has been in practice 29 years. She specializes in critical care medicine and pleural disease and is experienced in interstitial lung disease, critical care medicine, and pulmonary vascular disease.

Education & Training

University of North Carolina HospitalsFellowship, Pulmonary Disease and Critical Care Medicine, 1996 - 1999
University of Missouri-ColumbiaResidency, Internal Medicine, 1992 - 1995
University of Tripoli School of MedicineClass of 1988

Certifications & Licensure

CA State Medical License 2020 - 2026
TX State Medical License 2016 - 2021
OH State Medical License 2001 - 2018
NC State Medical License 1996 - 2005
American Board of Internal Medicine Critical Care Medicine
American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

Best Physicians in America 2016
Excellence in Teaching 2016
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Best Doctors in America 2005, 2007, 2009, 2011, 2013, 2015, 2017
Fellow American College of Chest Physicians
Fellow Pulmonary Vascular Research Institute
Join now to see all

Clinical Trials

Effects of the Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Pulmonary Arterial Hypertension (PAH) Start of enrollment: 2006 May 01
Completed
Phase 4
The Expression and Significance of MiRNA Start of enrollment: 2008 Jul 01
Completed
Ambrisentan in Patients With Porto-pulmonary Hypertension A Multicenter Open Label Trial Start of enrollment: 2010 Mar 01
Completed
Phase 3
Study in Subjects With PAH and PH Secondary to IPF Using Inhaled GeNOsyl. Start of enrollment: 2011 Mar 01
Completed
Phase 2
Phase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral Monotherapy Start of enrollment: 2012 Jun 26
Completed
Phase 3
An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension Start of enrollment: 2013 Sep 11
Completed
Phase 3
Study to Assess the Efficacy and Safety of Simtuzumab (GS-6624) in Adults With Idiopathic Pulmonary Fibrosis (IPF) Start of enrollment: 2013 Jan 31
Terminated
Phase 2
Tricuspid Regurgitant Jet Velocity as an Independent Marker for Mortality in Sickle Cell Anemia Start of enrollment: 2009 Dec 01
Completed
Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument Start of enrollment: 2013 Apr 01
Completed
Phase 3
Beraprost-314d Added-on to Tyvaso® (BEAT) Start of enrollment: 2013 May 31
Completed
Phase 3
Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT Start of enrollment: 2014 May 31
Completed
Phase 2
Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension RANGER Start of enrollment: 2017 Apr 18
Terminated
Phase 3
Join now to see all

Publications & Presentations

PubMed

Ralinepag Phase II Open-Label Extension Study in Patients with Pulmonary Arterial Hypertension.
Joan Barberà, Pavel Jansa, Elizabeth Klings, Arsen Ristić, Anne Keogh
Advances in Therapy. 2024-03-01
4 citations
Delphi consensus recommendation for optimization of pulmonary hypertension therapy focusing on switching from a phosphodiesterase 5 inhibitor to riociguat.
Franck F Rahaghi, Vijay P Balasubramanian, Robert C Bourge, Charles D Burger, Murali M Chakinala
Pulmonary Circulation. 2022-04-01
Lipoid Pneumonia: Fat Chance of Making the Diagnosis?
Namita Sood, Susan Murin
Chest. 2021-08-01

Journal Articles

Antithrombotic Therapy for VTE Disease CHEST Guideline and Expert Panel Report
Kearon C, Akl E A, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, Huisman M, King C S, Morris T A, Sood N, Stevens S M, Vintch J, Wells P, Woller S C, Moores L, Chest, 1/1/2016
An Official American Thoracic Society Clinical Practice Guideline: Diagnosis, Risk Stratification, and Management of Pulmonary Hypertension of Sickle Cell Disease
Klings E S, Machado R F, Barst R J, et al, American Journal of Respiratory and Critical Care Medicine, 1/1/2014
Macitentan for the Treatment of Pulmonary Arterial Hypertension
Sood N, Expert Opinion On Pharmacotherapy, 1/1/2014
Pharmacological Therapy for Pulmonary Arterial Hypertension in Adults CHEST Guidelines
Taichman D, Ornelas J, Chung L, Klinger J, Lewis S Z, Mandel J, Palevsky H, Stuart R, Sood N, Trow T, Yung R E C, Badesch D, Chest, 1/1/2014
Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studies
Barst R J; Mubarak K K, Machado R F; et al, British Journal of Haematology, 1/1/2013
Managing an Acutely Ill Patient with Pulmonary Arterial Hypertension
Sood N, Expert Review of Respiratory Medicine, 1/1/2013
Life-Threatening Variceal Hemorrhage in a Woman with Severe Pulmonary Hypertension
Almadani B, Sood N, Yearsley M, Lee W M., Gastroenterology & Hepatology, 1/1/2012
42-Year-Old Man With Fever, Shock, and Rash Recurrent toxic shock syndrome with associated staphylococcal scalded skin syndrome
Rahmanian S D, Molenda M, Fox C, et al, Chest, 1/1/2010
Community-acquired methicillin-resistant staphylococcus aureus epidural abscess with bacteremia and multiple lung abscesses: case report
Bruns A S and Sood N, American Journal of Critical Care, 1/1/2009
Massive Pulmonary embolism algorithm
Moseley M G, Crestanello J A, Sood N, J Emerg Med, 1/1/2008
Micrococcus Bacteremia in Patients with Pulmonary Hypertension Requiring Epoprostenol Infusion
Valdivia-Arenas M A and Sood N, Infectious Diseases in Clinical Practice, 1/1/2008
Lymphocytic interstitial pneumonia and pulmonary embolism in a patient with tetralogy of Fallot and common variable immunodeficiency: is there any link?
Valdivia-Arenas M A and Sood N, Thorax, 1/1/2008
Development of a triage protocol for patients presenting with gastrointestinal hemorrhage: a prospective cohort study
Das A M, Sood N, Hodgin K, et al, Critical Care, 1/1/2008
Pulmonary Hypertension and Sleep
Sood N, Clinics in Sleep Medicine, 1/1/2008
Pulmonary arterial hypertension and spina bifida
Brawner E J and Sood N, Chest, 1/1/2007
Pulmonary hypertension in Hodgkin's disease
Exline M, Magro C, Lin T, et al, Thorax, 1/1/2007
Non-tuberculous mycobacteria in end stage cystic fibrosis: implications for lung transplantation
Sood N, Chalermskulrat W, Neuringer I P, et al, Thorax, 1/1/2006
A 77-year-old farmer with respiratory failure and thrombocytopenia
Valdivia-Arenas M A and Sood N, Chest, 1/1/2006
Increasing concentration of inhaled saline with or without amiloride: Effect on mucociliary clearance in normal subjects
Sood N, Bennett W D, Zeman K, et al, American Journal of Respiratory and Critical Care Medicine, 1/1/2004
Pulmonary hypertension in sickle cell disease
Ataga K I and Sood N, De Gent G, et al, American Journal of Medicine, 1/1/2004
Effect of Varying Doses of Aerosolized Sodium Chloride Amiloride on Mucociliary Clearance in Normal Subjects
Sood N, Bennett W D, Zeman K L, Foy C, Boucher R C, Knowles M R., American Journal of Respir Crit Care Med, 1/1/2003
Outcomes of intensive care unit care in adults with cystic fibrosis
Sood N, Paradowski L J, Yankaskas J R., American Journal of Respiratory and Critical Care Medicine, 1/1/2001
Acute respiratory failure secondary to lymphangiatic carcinomatosis
Sood N, Banderenko N, Paradowski L J, Journal of Clinical Oncology, 1/1/2000
Join now to see all

Abstracts/Posters

Hemodynamic Effects of the Oral Prostacyclin (IP) Receptor Agonist Ralinepag in Pulmonary Arterial Hypertension.
Sood N, CHEST, 1/1/2017
Results of the Prospective, Multicenter, Single-Arm, Open-Label, Phase 4 MOTION Study of Riociguat in Pulmonary Arterial Hypertension
SoodN, Aranda A, Platt D, La Rose A, O Brien G, ATS, 1/1/2017
Baseline Demographics of the Prospective, Multicenter, Single-Arm, Open-Label, Phase IV MOTION Study of Riociguat in Pulmonary Arterial Hypertension
SoodN, Aranda A, Platt D, Mobin S, O Brien G.Satler C, ATS, 1/1/2016
Ambrisentan in Portopulmonary Hypertension, Results from the Multicenter Prospective ANGEL Study (AmbrisentaN usaGE in portopuLmonary hypertension)
Preston I, Burger C, Batterjee W, Bartolome S,Safdar Z, Kworka M, Sood N,F Hubert, Gromberg-Maitland M, Chakinala M, Hill N, ATS, 1/1/2016
Safety of Ambrisentan in Portopulmonary Hypertension, Result from the AmbrisentaN usaGE in PortopuLmonary Hypertension (ANGEL STUDY)
Batterjee W, Burger C, Bartolome S,Safdar Z, Kworka M, Sood N,F Hubert, Gromberg-Maitland M, Chakinala M, Hill N, Preston I, ATS, 1/1/2016
Age Cohort Comparison of Psychological and Physical Health in Adults with Pulmonary Hypertension.
Von Visger, T., Happ, M. B., Kuntz, K., Phillips, G., Sood, N, PhD Student Research Conference, Columbus, OH, 1/1/2015
Riociguat in Combination with Endothelin Receptor Antagonists (ERAs) for the Treatment of Pulmonary Arterial Hypertension (PAH): A Subgroup Analysis of PATENT.
Hill N and Sood N, Chest, 1/1/2015
Ambrisentan In Patients With Portopulmonary Hypertension: A Multicenter Open Label Trial
Preston I R, Burger C D , Krowka M, Safdar Z, Love H, Visnaw K, Sood N, Bartolome S, Ford H J, Kim N H, Poch D, Hill N S, ATS, 1/1/2014
Budget Cuts? Managing the Pulmonary Arterial Hypertension Medication Formulary While Being Cost Conscious for Your Institution.
Duvall L A and Sood N, PHA conference, 1/1/2014
Rapid Transition between Intravenous and Subcutaneous Treprostinil Infusions.
Duvall L, Norris L, Sood N, PHA conference, 1/1/2014
Prevalence of Psychological Issues among Patients with Pulmonary Hypertension.
VonVisger K K, Phillips G, Sood N, PHA conference, 1/1/2014
Prevalence of Psychological Distress Symptoms in Pulmonary Hypertension Patients. 2014 State of the Science Congress on Nursing Research.
Von Visger, T., Kuntz, K., Phillips, G., Happ, M.B., Sood, N, Council for the Advancement of Nursing Science, Washington, DC, 1/1/2014
Age Cohort Comparison of Psychological and Physical Health in Adults with Pulmonary Hypertension.
Von Visger, T., Kuntz, K., Phillips, G., Happ, M. B., Sood, N, Gerontological Society of America Conference & Scientific Session, Washington, DC, 1/1/2014
Pulmonary Hypertension: Psychological Aspects of the Disease.
Von Visger, T., Kuntz, K., Phillips, G., Happ, M.B., Sood, N, Ohio State University Wexner Medical Center Nursing Research Conference, Columbus, OH, 1/1/2014
The Prevalence of Psychological Distress in Pulmonary Hypertension.
Von Visger T, Kuntz K, Phillips G, Chipps E, Bauman J, Sood N, Pulmonary Hypertension Association Conference, 1/1/2012
Evaluation of the Incidence of Bloodstream Infections in Pulmonary Arterial Hypertension Patients Receiving Intravenous Prostacyclin Treatment.
Crist M, Bauer K, Sood N, Bazan J, Duvall L, Pulmonary Hypertension Association Conference, 1/1/2012
Clinical Nurse Specialist Influence on Safe Management of Hospitalized Pulmonary Hypertension Patients Requiring Prostacyclin Therapy.
VonVisger T, Sood N, Chipps E, Critical Care Nurse, 1/1/2011
Circulating MicroRNA in the Pathogenesis of Pulmonary Hypertension.
Sood N, Crawford M, Batte K, Wright V, Nana-Sinkam P S, CHEST Conference, 1/1/2010
Does an isolated Increase in TR Jet Velocity as Measured by 2D Echocardiography Independently Predict an Increased Mortality in Patients with Sickle Cell Disease.
Gorbett D, Kraut E, Mann-Jiles V, Sood N, CHEST Conference, 1/1/2010
Exercise Capacity and Hemodynamics in Sickle Cell Disease with Pulmonary Hypertension.
Barst R, Machado R, Mubarak K, Sood N, Gladwin M, CHEST Conference, 1/1/2010
The Effects of Obstructive Sleep Apnea on Pulmonary Arterial Pressures: A Retrospective Chart Review at One Academic Medical Center.
Strack L K, Kynyk J, Phillips G, Haden D, Magalang U, Sood N, OSU Research Day, 1/1/2009
Collaboration Improves Patient Care Outcomes: A Team Approach to Inpatient Management of Pulmonary Arterial Hypertension (PAH) Patients Requiring Prostacyclin Therapy.
Von Visger T, Voth L, Tussing T, Matula L, Sood N, PH Resource Network Symposium, 1/1/2009
Brand or Generic? Evaluation of an Epoprostenol Formulary Change.
Duvall L and Sood N, International Pulmonary Hypertension Conference, 1/1/2009
Selective Vasodilator Therapy in the Treatment of Pulmonary Arterial Hypertension in the Setting of Obstructive Sleep Apnea.
Strack L, Kynyk J, Phillips G, Haden G, Magalang U, Sood N, American Thoracic Society Conference, 1/1/2009
The Effects of Obstructive Sleep Apnea on Pulmonary Arterial Pressures: A Retrospective Chart Review at One Academic Medical Center.
Kynyk J, Strack L K, Phillips G, Haden D, Sood N, American Thoracic Society Conference, 1/1/2009
Join now to see all

Lectures

Management of Pulmonary Arterial Hypertension
Blanchard Valley Hospital, Findlay, OH, 2008; University of Texas Health Science Center at Houston, - 1/1/2017
Special Consideration Regarding Altiltude/ Flying / Diving.
University of Texas Health Science Center at Houston - 1/1/2017
Case Studies in Pulmonary vascular Disease
University of Texas Health Science Center at Houston - 1/1/2017
Pulmonary Alveolar Proteinosis Presenting as Dyspnea and Thrush
1/1/2017
Diagnosis and Treatment of Pulmonary Embolism
University of Texas Health Science Center at Houston - 1/1/2017
Ohio State University
Ohio State University - 1/1/2016
Biomarkers as the treatment goal for PH
1/1/2016
Is It Efficacious to Switch from Infusion to Oral Therapy for Pulmonary Arterial Hypertension?
1/1/2016
An Unusual Cause of Hypoxia.
1/1/2016
Management of a Critically Ill Patient with Pulmonary Arterial Hypertension
University of Cincinnati - 1/1/2015
Pulmonary Arterial Hypertension (Graduate Level)
Ohio State University, Columbus, OH - 1/1/2014
Pulmonary Arterial Hypertension Diagnosis and Treatment
Ohio State University - 1/1/2014
Treatment of Pulmonary Embolism
Ohio State University - 1/1/2014
Overview of Pulmonary Arterial Hypertension
Ohio State University - 1/1/2013
The Pharmacist's Role in Managing Pulmonary Arterial Hypertension
Stony Brook Medical Center, Long Island, NY - 1/1/2013
Treatment of Pulmonary Arterial Hypertension
Ohio State University - 1/1/2013
Pulmonary Hypertension in Sleep Apnea.
Chicago, IL - 1/1/2013
Risk Stratification in Acute Pulmonary Embolism.
Chicago, IL - 1/1/2013
Treatment of Pulmonary Arterial Hypertension.
Vancouver, Canada - 1/1/2013
Case Studies in PAH.
Philadelphia, PA, 2013; Chicago, IL, 2013 - 1/1/2013
Treatment of Pulmonary Embolism: PRo con Debate
Ohio State University, Columbus, OH - 1/1/2013
Pulmonary Arterial Hypertension Present and the Future
Fairfield Medical Center, Lancaster, OH - 1/1/2013
Pulmonary Arterial Hypertension in Autoimmune Diseases
Ohio State University - 1/1/2013
Pulmonary Mycobacterium Avium Complex Infection In A Renal Transplant Patient Suspected Of Having Tuberculosis
1/1/2013
Pulmonary Arterial Hypertension and HIV
Ohio State University - 1/1/2012
Join now to see all